Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA
- 1 June 1997
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 25 (11) , 2167-2173
- https://doi.org/10.1093/nar/25.11.2167
Abstract
We have tested the inhibitory potential of peptide nucleic acid (PNA) on in vitro reverse transcription of the HIV-1 gag gene. PNA was designed to target different regions of the HIV-1 gag gene and the effect on reverse transcription by HIV-1, MMLV and AMV reverse transcriptases (RTs) was investigated. We found that a bis-PNA (parallel antisense 10mer linked to antiparallel antisense 10mer) was superior to both the parallel antisense 10mer and antiparallel antisense 10mer in inhibiting reverse transcription of the gene, thus indicating triplex formation at the target sequence. A complete arrest of reverse transcription was obtained at approximately 6-fold molar excess of the bis-PNA with respect to the gag RNA. At this molar ratio we found no effect on in vitro translation of gag RNA. A 15mer duplex-forming PNA was also found to inhibit reverse transcription at very low molar ratios of PNA/ gag RNA. Specificity of the inhibition of reverse transcription by PNA was confirmed by RNA sequencing, which revealed that all tested RTs were stopped by the PNA/RNA complex at the predicted site. We propose that the effect of PNA is exclusively due to steric hindrance, as we found no signs of RNA degradation that would indicate PNA-mediated RNase H activation of the tested RTs. In conclusion, PNA appears to have a potential to become a specific and efficient inhibitor of reverse transcription in vivo , provided sufficient intracellular levels are achievable.Keywords
This publication has 24 references indexed in Scilit:
- Alternate Strand DNA Triple Helix-mediated Inhibition of HIV-1 U5 Long Terminal Repeat Integration in VitroPublished by Elsevier ,1996
- Effect of Human Immunodeficiency Virus Type 1 (HIV-1) Nucleocapsid Protein on HIV-1 Reverse Transcriptase Activity in VitroBiochemistry, 1996
- Phosphorothioate Oligonucleotides Block Reverse Transcription by the RNase-H Activity Associated with the HIV-1 PolymeraseBiochemical and Biophysical Research Communications, 1995
- Solid‐Phase synthesis of peptide nucleic acidsJournal of Peptide Science, 1995
- Inhibition of HIV-1 Reverse Transcriptase by Defined Template/Primer DNA Oligonucleotides: Effect of Template Length and Binding CharacteristicsJournal of Enzyme Inhibition, 1994
- Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotidesFEBS Letters, 1993
- Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?Pharmacology & Therapeutics, 1991
- Endoribonucleolytic cleavage of RNA: Oligodeoxynucleotide hybrids by the ribonuclease H activity of HIV-1 reverse transcriptaseBiochemical and Biophysical Research Communications, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Cleavage of HIV-1gagPolyprotein Synthesized In Vitro: Sequential Cleavage by the Viral ProteaseAIDS Research and Human Retroviruses, 1989